#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA750554	F	In vivo agonist efficacy as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assay		5	ALA1126196	organism-based format	Scientific Literature
2.	ALA750555	F	In vivo agonist efficacy was determined as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assay.		11	ALA1126196	organism-based format	Scientific Literature
3.	ALA750556	F	In vivo potency as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assay		5	ALA1126196	organism-based format	Scientific Literature
4.	ALA750557	F	In vivo potency was determined as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assay.		11	ALA1126196	organism-based format	Scientific Literature
5.	ALA750770	F	Compound was evaluated for the inhibition of serum-opsonized zymosan stimulated myeloperoxidase release from human neutrophil	Homo sapiens	1	ALA1126285	assay format	Scientific Literature
6.	ALA750777	F	Tested in vivo for the ability to inhibit myeloperoxidase (MPO) activity in the colon of the TNB/ethanol-induced chronic colitis rats at the dosage of 100 mg/kg/day	Rattus norvegicus	6	ALA1127462	organism-based format	Scientific Literature
7.	ALA750778	F	Tested in vivo for the ability to inhibit myeloperoxidase (MPO) activity in the colon of the TNB/ethanol-induced chronic colitis rats at the dosage of 500 mg/kg/day	Rattus norvegicus	1	ALA1127462	organism-based format	Scientific Literature
8.	ALA840669	F	Ability to inhibit C5a-induced release of azurophilic granular constituent myeloperoxidase (MPO) from intact neutrophils		1	ALA1126141	assay format	Scientific Literature
9.	ALA841524	F	Compound was tested for the induction of nonspecific myeloperoxidase (MPO) release		5	ALA1126141	assay format	Scientific Literature
10.	ALA931190	B	Inhibition of chlorinating activity of recombinant myeloperoxidase by taurine assay		13	ALA1141613	tissue-based format	Scientific Literature
11.	ALA932250	B	Inhibition of chlorinating activity of recombinant myeloperoxidase at 0.5 uM by taurine assay		12	ALA1141613	tissue-based format	Scientific Literature
12.	ALA932251	B	Inhibition of chlorinating activity of recombinant myeloperoxidase at 1 uM by taurine assay		12	ALA1141613	tissue-based format	Scientific Literature
13.	ALA932252	B	Inhibition of chlorinating activity of recombinant myeloperoxidase at 2 uM by taurine assay		12	ALA1141613	tissue-based format	Scientific Literature
14.	ALA932253	B	Inhibition of chlorinating activity of recombinant myeloperoxidase at 4 uM by taurine assay		12	ALA1141613	tissue-based format	Scientific Literature
15.	ALA1027367	B	Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells by spectrophotometrically	Homo sapiens	2	ALA1152752	cell-based format	Scientific Literature
16.	ALA1027368	B	Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells at 10 uM by spectrophotometrically	Homo sapiens	2	ALA1152752	cell-based format	Scientific Literature
17.	ALA1027369	B	Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells at 50 uM by spectrophotometrically	Homo sapiens	2	ALA1152752	cell-based format	Scientific Literature
18.	ALA1287076	B	Inhibition of human myeloperoxidase at 10 uM	Homo sapiens	1	ALA1275350	single protein format	Scientific Literature
19.	ALA1640944	B	Inhibition of recombinant MPO assessed as rate of electron donation to MPO redox intermediate compound I by sequential mixing stopped flow spectroscopy		2	ALA1629449	single protein format	Scientific Literature
20.	ALA1640945	B	Inhibition of recombinant MPO mediated taurine chlorination by microplate reader method		24	ALA1629449	tissue-based format	Scientific Literature